WHO Grade 3 Glioma — Trials

WHO Grade 3 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03244995	Mind-Body Intervention in Glioma Couples	active not recruiting	N/A	74	M.D. Anderson Cancer CenterOTHER	1	Aug 12, 2026	clinicaltrials
NCT03251027	Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma	active not recruiting	N/A	100	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	Jan 27, 2026	clinicaltrials